A 60-year-old woman with a past medical history of asthma presented with fulminant myocarditis 9 days after testing positive for SARS-CoV-2 and 16 days after developing symptoms consistent with COVID-19. Her hospital course was complicated by the need for veno-arterial extracorporeal membrane oxygenation, ventricular arrhythmias, and pseudomonas bacteremia. She ultimately recovered and was discharged to home with normal left ventricular systolic function. Thereafter, she developed symptomatic ventricular tachycardia, for which she received an implantable cardioverter-defibrillator and antiarrhythmic drug therapy.
Keywords: CMR, cardiac magnetic resonance; COVID-19; CRRT, continuous renal replacement therapy; EMB, endomyocardial biopsy; LVEF, left ventricular ejection fraction; VA ECMO, veno-arterial extracorporeal membrane oxygenation; VT, ventricular tachycardia; fulminant myocarditis; hs-TnT, high-sensitivity troponin T; ventricular arrhythmias.
© 2022 by the American College of Cardiology Foundation. Published by Elsevier.